Browse > Article
http://dx.doi.org/10.3343/alm.2018.38.6.518

Removing Lipemia in Serum/Plasma Samples: A Multicenter Study  

Castro-Castro, Maria-Jose (Clinical Laboratory, Bellvitge University Hospital)
Candas-Estebanez, Beatriz (Clinical Laboratory, Bellvitge University Hospital)
Esteban-Salan, Margarita (Biochemitry Service, Cruces University Hospital)
Calmarza, Pilar (Laboratory of Clinical Biochemistry, Miguel Servet University Hospital)
Arrobas-Velilla, Teresa (Laboratory of Clinical Biochemistry, Virgen del Rocio University Hospital)
Romero-Roman, Carlos (Laboratory of Clinical Biochemistry, Albacete Hospital)
Pocovi-Mieras, Miguel (Department of Biochemistry and Molecular and Cellular Biology, University of Zaragoza)
Aguilar-Doreste, Jose-Angel (Laboratory of Clinical Biochemistry, Gran Canaria Dr. Negrin University Hospital, Las Palmas de Gran Canaria)
Commission on Lipoprotein and Vascular Diseases, Sociedad Espanola de Quimica Clinica (Sociedad Espanola de Quimica Clinica)
Publication Information
Annals of Laboratory Medicine / v.38, no.6, 2018 , pp. 518-523 More about this Journal
Abstract
Background: Lipemia, a significant source of analytical errors in clinical laboratory settings, should be removed prior to measuring biochemical parameters. We investigated whether lipemia in serum/plasma samples can be removed using a method that is easier and more practicable than ultracentrifugation, the current reference method. Methods: Seven hospital laboratories in Spain participated in this study. We first compared the effectiveness of ultracentrifugation ($108,200{\times}g$) and high-speed centrifugation ($10,000{\times}g$ for 15 minutes) in removing lipemia. Second, we compared high-speed centrifugation with two liquid-liquid extraction methods-LipoClear (StatSpin, Norwood, USA), and 1,1,2-trichlorotrifluoroethane (Merck, Darmstadt, Germany). We assessed 14 biochemical parameters: serum/plasma concentrations of sodium ion, potassium ion, chloride ion, glucose, total protein, albumin, creatinine, urea, alkaline phosphatase, gamma-glutamyl transferase, alanine aminotransferase, aspartate-aminotransferase, calcium, and bilirubin. We analyzed whether the differences between lipemia removal methods exceeded the limit for clinically significant interference (LCSI). Results: When ultracentrifugation and high-speed centrifugation were compared, no parameter had a difference that exceeded the LCSI. When high-speed centrifugation was compared with the two liquid-liquid extraction methods, we found differences exceeding the LCSI in protein, calcium, and aspartate aminotransferase in the comparison with 1,1,2-trichlorotrifluoroethane, and in protein, albumin, and calcium in the comparison with LipoClear. Differences in other parameters did not exceed the LCSI. Conclusions: High-speed centrifugation ($10,000{\times}g$ for 15 minutes) can be used instead of ultracentrifugation to remove lipemia in serum/plasma samples. LipoClear and 1,1,2-trichlorotrifluoroethane are unsuitable as they interfere with the measurement of certain parameters.
Keywords
Lipemia; Interference; Lipid removal method; High-speed centrifugation; LipoClear; 1,1,2-trichlorotrifluoroethane;
Citations & Related Records
연도 인용수 순위
  • Reference
1 CLSI. Statistical quality control for quantitative measurement procedures: principles and definitions; approved guideline. 3rd Ed. CLSI C24-A3. Wayne, PA: Clinical Laboratory Standards Institute. 2006.
2 Spanish Society of Clinical Biochemistry and Molecular Pathology. Criteria for the assessment of the analytical and clinical significance of interferences in clinical biochemistry. Quim Clinica 1995;14:107-9.
3 Kroll M. Evaluating interference caused by lipaemia. Clin Chem 2004;50:1968-9.   DOI
4 Farrell CL and Carter AC. Serum indices : managing assay interference. Ann Clin Biochem 2016;53:527-38.   DOI
5 Ryder KW, Glick MR, (Ascp) M, Glick SJ. Incidence and amount of turbidity, hemolysis, and icterus in serum from outpatients. Lab Med 1991;22:415-8.   DOI
6 Nikolac N. Lipaemia: causes, interference mechanisms, detection and management. Biochem Med 2014;24:57-67.
7 Dimeski G and Jones BW. Lipaemic samples: effective process for lipid reduction using high speed centrifugation compared with ultracentrifugation. Biochem Med (Zagreb) 2011;21:86-92.
8 Goldenberg NM, Wang P, Glueck CJ. An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia. Clin Chim Acta 2003; 332:11-9.   DOI
9 Calmarza P and Cordero J. Lipaemia interferences in routine clinical biochemical tests. Biochem Med 2011;21:160-6.
10 Walker PL and Crook MA. Lipaemia: causes, consequences and solutions. Clin Chim Acta 2013;418:30-2.   DOI
11 CLSI. Hemolysis, icterus, and lipaemia/turbidity indices as indicators of interference in clinical laboratory analysis. 1st ed. CLSI C56. Wayne, PA: Clinical and Laboratory Standards Institute. 2011.
12 Vermeer HJ, Steen G, Naus JM, Goevaerts B, Pauline T, Schoenmakers CHH. Correction of patient results for Beckman Coulter LX-20 assays affected by interference due to hemoglobin, bilirubin or lipids : a practical approach. Clin Chem Lab Med 2007;45:114-9.
13 Saracevic A, Nikolac N, Simundic A. The evaluation and comparison of consecutive high speed centrifugation and $LipoClear^{(R)}$ reagent for lipaemia removal. Clin Biochem 2014;47:309-14.   DOI
14 Bergmeyer HU, Horder M, Rej R. Approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase. J Clin Chem Clin Biochem 1986;24:481-95.
15 Dimeski G. Interference testing. Clin Biochem Rev 2008;29(S1):S43-8.
16 Bergmeyer HU, Horder M, Rej R. Approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. IFCC Method for aspartate aminotransferase. J Clin Chem Clin Biochem 1986;24:497-510.
17 Tietz NW, Rinker AD, Shaw LM. International Federation of Clinical Chemistry. IFCC methods for the measurement of catalytic concentration of enzymes, Part 5. IFCC method for alkaline phosphatase (orthophosphoric-monoester phosphohydrolase, alkaline optimum, EC 3.1.3.1). J Clin Chem Clin Biochem 1983;21:731-48.
18 Szasz G. New substrates for measuring gamma-glutamyl-transpeptidase activity. Z Klin Chem Klin Biochem 1974;12:228.